Verification evidence is still being completed.
PDF / print export
Blueprint Genetics
Espoo, Finland
- Verified lead
- Juhana Rauramo
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Vice President and General Manager; Managing Director
- 2026 technical specialization
- Rare-Disease Genetic Testing, Genomic Diagnostics, and Clinical Interpretation
- Review cycle
- May 2026
- Full address
- Keilaranta 16 A-B, 02150 Espoo, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Blueprint Genetics announcement confirming the current operating lead in Finland.
- Editorial note
- The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director mandate for the Helsinki-based business.
Rare-Disease Genetic Testing, Genomic Diagnostics, and Clinical Interpretation
CAP accreditation, CLIA certification, ISO 15189:2022 (FINAS), CE-marked IVD platform
The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director mandate for the Helsinki-based business.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director…
- Lead
- Juhana Rauramo (verified ↗)
- Address
- Keilaranta 16 A-B, 02150 Espoo, Finland (source ↗)
- Compliance
- ISO 15189:2022 (FINAS) · CE-marked IVD platform
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Global clinical genetic testing from Espoo
- Capabilities
- Genetic Panel Testing · Whole Exome and Genome Sequencing · Clinical Genetics Support
- Founded
- 2012
- Headcount
- 201-500
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Juhana Rauramo
Vice President and General Manager; Managing Director
Full addressKeilaranta 16 A-B, 02150 Espoo, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Blueprint Genetics contact page listing the Keilaranta 16 A-B Espoo office and sample-shipping address.
Open sourceGlobal clinical genetic testing from Espoo
Espoo, Finland. Rare-Disease Genetic Testing, Genomic Diagnostics, and Clinical Interpretation. Review completed on 21 Mar 2026.
CAP, CLIA, FINAS, and EU IVD quality oversight
CAP accreditation, CLIA certification, ISO 15189:2022 (FINAS), CE-marked IVD platform
Rare-Disease Genetic Testing, Genomic Diagnostics, and Clinical Interpretation
The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director mandate for the Helsinki-based business.
Editorial note
The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director mandate for the Helsinki-based business.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Genetic Panel Testing
Whole Exome and Genome Sequencing
Clinical Genetics Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Next-generation sequencing laboratory
Clinical interpretation platform
Specimen logistics and reporting systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Blueprint Genetics located?
- Blueprint Genetics operates from Keilaranta 16 A-B, 02150 Espoo, Finland, Espoo, Finland.
- Who runs Blueprint Genetics?
- Blueprint Genetics is led by Juhana Rauramo, Vice President and General Manager; Managing Director. Verified 21 Mar 2026.
- What certifications does Blueprint Genetics hold?
- Blueprint Genetics is documented under ISO 15189:2022 (FINAS), CE-marked IVD platform.
- What does Blueprint Genetics do?
- The registry uses Juhana Rauramo as the current published operating lead because Blueprint's 4 December 2025 official release assigns him both the Vice President and General Manager role and the managing-director… Core capabilities: Genetic Panel Testing, Whole Exome and Genome Sequencing, Clinical Genetics Support.
Editorial context
Related technical briefs
Briefs that name Espoo as a covered market or city.